Sagittarius Life Science Cash Flow Conversion Efficiency
Sagittarius Life Science cash flow conversion efficiency. Based on the latest financial reports, Sagittarius Life Science (3205) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-21.27 Million ≈ $-670.00K USD) by net assets (NT$1.04 Billion ≈ $32.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sagittarius Life Science (2015–2025)
Cash flow conversion efficiency of Sagittarius Life Science from 2015 to 2025. This chart illustrates how Sagittarius Life Science's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 3205 live share price for real-time trading data and today's change.
Sagittarius Life Science Cash Flow Conversion Ratio Explained
Sagittarius Life Science cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sagittarius Life Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sagittarius Life Science ranked by their cash flow conversion efficiency. Also see Sagittarius Life Science stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
eWork Group AB
ST:EWRK
|
0.340x |
|
Lakeshore Acquisition III Corp. Ordinary Shares
NASDAQ:LCCC
|
0.159x |
|
Super Energy Corporation Public Company Limited
BK:SUPER
|
0.039x |
|
Ablerex Electronics Co Ltd
TWO:3628
|
0.105x |
|
J Sainsbury PLC
LSE:SBRY
|
0.419x |
|
GAMSUNG Corporation Co. Ltd
KQ:036620
|
-0.037x |
|
Sergeferrari G
PA:SEFER
|
0.064x |
|
Interlink Telecom Public Company Limited
BK:ITEL
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Sagittarius Life Science (2015–2025)
The table below shows the annual cash flow conversion efficiency of Sagittarius Life Science from 2015 to 2025. Review 3205 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.04 Billion ≈ $32.92 Million |
NT$-36.05 Million ≈ $-1.14 Million |
-0.035x | +67.44% |
| 2024-12-31 | NT$419.76 Million ≈ $13.22 Million |
NT$-44.48 Million ≈ $-1.40 Million |
-0.106x | +19.51% |
| 2023-12-31 | NT$526.90 Million ≈ $16.60 Million |
NT$-69.37 Million ≈ $-2.19 Million |
-0.132x | -13.36% |
| 2022-12-31 | NT$455.42 Million ≈ $14.35 Million |
NT$-52.89 Million ≈ $-1.67 Million |
-0.116x | -111.62% |
| 2021-12-31 | NT$531.71 Million ≈ $16.75 Million |
NT$-29.18 Million ≈ $-919.36K |
-0.055x | +48.12% |
| 2020-12-31 | NT$588.38 Million ≈ $18.54 Million |
NT$-62.24 Million ≈ $-1.96 Million |
-0.106x | +31.72% |
| 2019-12-31 | NT$674.50 Million ≈ $21.25 Million |
NT$-104.50 Million ≈ $-3.29 Million |
-0.155x | -113.51% |
| 2018-12-31 | NT$797.37 Million ≈ $25.12 Million |
NT$-57.86 Million ≈ $-1.82 Million |
-0.073x | -200.52% |
| 2017-12-31 | NT$965.47 Million ≈ $30.42 Million |
NT$-23.31 Million ≈ $-734.49K |
-0.024x | -108.12% |
| 2016-12-31 | NT$1.21 Billion ≈ $38.18 Million |
NT$360.37 Million ≈ $11.35 Million |
0.297x | -10.68% |
| 2015-12-31 | NT$714.71 Million ≈ $22.52 Million |
NT$237.94 Million ≈ $7.50 Million |
0.333x | -- |
About Sagittarius Life Science
Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.